Copyright Reports & Markets. All rights reserved.

Global Subcutaneous Injection Immunoglobulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Subcutaneous Injection Immunoglobulin
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Subcutaneous Injection Immunoglobulin Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 10% Purity
    • 1.3.3 20% Purity
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Subcutaneous Injection Immunoglobulin Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Primary Immunodeficiency
    • 1.4.3 Secondary Immunodeficiency
    • 1.4.4 Others
  • 1.5 Global Subcutaneous Injection Immunoglobulin Market Size & Forecast
    • 1.5.1 Global Subcutaneous Injection Immunoglobulin Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Subcutaneous Injection Immunoglobulin Sales Quantity (2019-2030)
    • 1.5.3 Global Subcutaneous Injection Immunoglobulin Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Takeda
    • 2.1.1 Takeda Details
    • 2.1.2 Takeda Major Business
    • 2.1.3 Takeda Subcutaneous Injection Immunoglobulin Product and Services
    • 2.1.4 Takeda Subcutaneous Injection Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Takeda Recent Developments/Updates
  • 2.2 Grifols
    • 2.2.1 Grifols Details
    • 2.2.2 Grifols Major Business
    • 2.2.3 Grifols Subcutaneous Injection Immunoglobulin Product and Services
    • 2.2.4 Grifols Subcutaneous Injection Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Grifols Recent Developments/Updates
  • 2.3 CSL
    • 2.3.1 CSL Details
    • 2.3.2 CSL Major Business
    • 2.3.3 CSL Subcutaneous Injection Immunoglobulin Product and Services
    • 2.3.4 CSL Subcutaneous Injection Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CSL Recent Developments/Updates

3 Competitive Environment: Subcutaneous Injection Immunoglobulin by Manufacturer

  • 3.1 Global Subcutaneous Injection Immunoglobulin Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Subcutaneous Injection Immunoglobulin Revenue by Manufacturer (2019-2024)
  • 3.3 Global Subcutaneous Injection Immunoglobulin Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Subcutaneous Injection Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Subcutaneous Injection Immunoglobulin Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Subcutaneous Injection Immunoglobulin Manufacturer Market Share in 2023
  • 3.5 Subcutaneous Injection Immunoglobulin Market: Overall Company Footprint Analysis
    • 3.5.1 Subcutaneous Injection Immunoglobulin Market: Region Footprint
    • 3.5.2 Subcutaneous Injection Immunoglobulin Market: Company Product Type Footprint
    • 3.5.3 Subcutaneous Injection Immunoglobulin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Subcutaneous Injection Immunoglobulin Market Size by Region
    • 4.1.1 Global Subcutaneous Injection Immunoglobulin Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Subcutaneous Injection Immunoglobulin Consumption Value by Region (2019-2030)
    • 4.1.3 Global Subcutaneous Injection Immunoglobulin Average Price by Region (2019-2030)
  • 4.2 North America Subcutaneous Injection Immunoglobulin Consumption Value (2019-2030)
  • 4.3 Europe Subcutaneous Injection Immunoglobulin Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Subcutaneous Injection Immunoglobulin Consumption Value (2019-2030)
  • 4.5 South America Subcutaneous Injection Immunoglobulin Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Subcutaneous Injection Immunoglobulin Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Subcutaneous Injection Immunoglobulin Sales Quantity by Type (2019-2030)
  • 5.2 Global Subcutaneous Injection Immunoglobulin Consumption Value by Type (2019-2030)
  • 5.3 Global Subcutaneous Injection Immunoglobulin Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Subcutaneous Injection Immunoglobulin Sales Quantity by Application (2019-2030)
  • 6.2 Global Subcutaneous Injection Immunoglobulin Consumption Value by Application (2019-2030)
  • 6.3 Global Subcutaneous Injection Immunoglobulin Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Subcutaneous Injection Immunoglobulin Sales Quantity by Type (2019-2030)
  • 7.2 North America Subcutaneous Injection Immunoglobulin Sales Quantity by Application (2019-2030)
  • 7.3 North America Subcutaneous Injection Immunoglobulin Market Size by Country
    • 7.3.1 North America Subcutaneous Injection Immunoglobulin Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Subcutaneous Injection Immunoglobulin Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Subcutaneous Injection Immunoglobulin Sales Quantity by Type (2019-2030)
  • 8.2 Europe Subcutaneous Injection Immunoglobulin Sales Quantity by Application (2019-2030)
  • 8.3 Europe Subcutaneous Injection Immunoglobulin Market Size by Country
    • 8.3.1 Europe Subcutaneous Injection Immunoglobulin Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Subcutaneous Injection Immunoglobulin Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size by Region
    • 9.3.1 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Subcutaneous Injection Immunoglobulin Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Subcutaneous Injection Immunoglobulin Sales Quantity by Type (2019-2030)
  • 10.2 South America Subcutaneous Injection Immunoglobulin Sales Quantity by Application (2019-2030)
  • 10.3 South America Subcutaneous Injection Immunoglobulin Market Size by Country
    • 10.3.1 South America Subcutaneous Injection Immunoglobulin Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Subcutaneous Injection Immunoglobulin Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Subcutaneous Injection Immunoglobulin Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Subcutaneous Injection Immunoglobulin Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Subcutaneous Injection Immunoglobulin Market Size by Country
    • 11.3.1 Middle East & Africa Subcutaneous Injection Immunoglobulin Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Subcutaneous Injection Immunoglobulin Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Subcutaneous Injection Immunoglobulin Market Drivers
  • 12.2 Subcutaneous Injection Immunoglobulin Market Restraints
  • 12.3 Subcutaneous Injection Immunoglobulin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Subcutaneous Injection Immunoglobulin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Subcutaneous Injection Immunoglobulin
  • 13.3 Subcutaneous Injection Immunoglobulin Production Process
  • 13.4 Subcutaneous Injection Immunoglobulin Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Subcutaneous Injection Immunoglobulin Typical Distributors
  • 14.3 Subcutaneous Injection Immunoglobulin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Subcutaneous Injection Immunoglobulin market size was valued at USD 1918 million in 2023 and is forecast to a readjusted size of USD 2799.4 million by 2030 with a CAGR of 5.6% during review period.
    Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
    The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
    The Global Info Research report includes an overview of the development of the Subcutaneous Injection Immunoglobulin industry chain, the market status of Primary Immunodeficiency (10% Purity, 20% Purity), Secondary Immunodeficiency (10% Purity, 20% Purity), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Subcutaneous Injection Immunoglobulin.
    Regionally, the report analyzes the Subcutaneous Injection Immunoglobulin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Subcutaneous Injection Immunoglobulin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Subcutaneous Injection Immunoglobulin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Subcutaneous Injection Immunoglobulin industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 10% Purity, 20% Purity).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Subcutaneous Injection Immunoglobulin market.
    Regional Analysis: The report involves examining the Subcutaneous Injection Immunoglobulin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Subcutaneous Injection Immunoglobulin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Subcutaneous Injection Immunoglobulin:
    Company Analysis: Report covers individual Subcutaneous Injection Immunoglobulin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Subcutaneous Injection Immunoglobulin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Primary Immunodeficiency, Secondary Immunodeficiency).
    Technology Analysis: Report covers specific technologies relevant to Subcutaneous Injection Immunoglobulin. It assesses the current state, advancements, and potential future developments in Subcutaneous Injection Immunoglobulin areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Subcutaneous Injection Immunoglobulin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Subcutaneous Injection Immunoglobulin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    10% Purity
    20% Purity
    Market segment by Application
    Primary Immunodeficiency
    Secondary Immunodeficiency
    Others
    Major players covered
    Takeda
    Grifols
    CSL
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Subcutaneous Injection Immunoglobulin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Subcutaneous Injection Immunoglobulin, with price, sales, revenue and global market share of Subcutaneous Injection Immunoglobulin from 2019 to 2024.
    Chapter 3, the Subcutaneous Injection Immunoglobulin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Subcutaneous Injection Immunoglobulin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Subcutaneous Injection Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Subcutaneous Injection Immunoglobulin.
    Chapter 14 and 15, to describe Subcutaneous Injection Immunoglobulin sales channel, distributors, customers, research findings and conclusion.

    Buy now